Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BH3-only and pro-apoptotic BCL-2 family proteins are critical regulators of the intrinsic (mitochondrial) pathway of apoptosis, serving as sensors of cellular stress and executioners of programmed cell death [Source: PubMed, UniProt]. This functional group includes activator and sensitizer BH3-only proteins, such as BIM, BID, PUMA, and NOXA, as well as the effector proteins BAX and BAK, which directly mediate mitochondrial outer membrane permeabilization (MOMP) [Source: Nature Reviews Molecular Cell Biology]. These proteins respond to various stress signals, including DNA damage and growth factor withdrawal, by initiating a cascade that leads to the release of cytochrome c from the mitochondria [Source: NIH]. In many cancers, the activity of these pro-apoptotic proteins is neutralized by the overexpression of anti-apoptotic BCL-2 family members, which sequester them to prevent cell death and promote tumor survival [Source: Cell Death & Differentiation]. Therapeutic intervention primarily involves BH3 mimetics, such as Venetoclax, which are small molecules designed to mimic the BH3 domain of pro-apoptotic proteins to inhibit anti-apoptotic proteins and restore the apoptotic signal [Source: FDA, PubMed]. These targets are pivotal in the treatment of hematologic malignancies and are currently being explored for their potential in treating various solid tumors [Source: PubMed].
BH3 mimetics function by binding to the hydrophobic surface groove of anti-apoptotic BCL-2 family proteins (e.g., BCL-2, BCL-XL, MCL-1), which normally sequester pro-apoptotic BH3-only proteins and effectors like BAX and BAK [Source: PubMed]. By occupying this groove, the drugs displace the pro-apoptotic proteins, allowing BAX and BAK to undergo conformational changes, oligomerize, and form pores in the mitochondrial outer membrane [Source: Nature Reviews]. This process, known as mitochondrial outer membrane permeabilization (MOMP), leads to the release of cytochrome c and other pro-apoptotic factors into the cytosol, activating the caspase cascade and resulting in rapid cell death [Source: UniProt].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BH3-only and pro-apoptotic BCL-2 family proteins (BH3-only proteins).